
Embecta Corp.
NASDAQ:EMBC
13.3 (USD) • At close May 8, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Embecta Corp. |
Symbool | EMBC |
Munteenheid | USD |
Prijs | 13.3 |
Beurswaarde | 773,187,972 |
Dividendpercentage | 4.11% |
52-weken bereik | 10.83 - 21.48 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Devdatt Kurdikar |
Website | https://www.embecta.com |
An error occurred while fetching data.
Over Embecta Corp.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)